Alert
Recommended Alerts
DOJ Increases Focus on Clinical Trial Fraud
While speaking at the Food & Drug Law Institute’s Enforcement, Litigation and Compliance Conference in December, Deputy Assistant Attorney General Arun Rao identified clinical trial fraud as one of four key areas of enforcement focus by the Consumer Protection Branch of the U.S. Department of Justice (“DOJ”).